LPL and B-cell non-Hodgkin lymphoma: In various conditions—including CLL, LPL, monoclonal B cell lymphocytosis, and non-Hodgkin B-cell lymphoma (NHBCL)—the immunological parameters post-RZV are reduced compared to the general population, and a more pronounced reduction was observed in NHBCL patients.